Dorman Products Inc. (DORM) Drops 5.44% on January 27

Equities Staff |

Dorman Products Inc. (DORM) was one of the Russell 2000's biggest losers for Wednesday January 27 as the stock slid 5.44% to $41.91, a loss of $-2.41 per share. Starting at an opening price of $44.32 a share, the stock traded between $41.85 and $44.43 over the course of the trading day. Volume was 433,071 shares over 3,358 trades, against an average daily volume of 263,251 shares and a total float of 35.5 million.

The losses send Dorman Products Inc. down to a market cap of $1.49 billion. In the last year, Dorman Products Inc. has traded between $53.75 and $40.79, and its 50-day SMA is currently $46.25 and 200-day SMA is $48.74.

The stock has a P/E Ratio of 17.7.

Dorman Products Inc is a supplier of replacement parts and fasteners for passenger cars, light trucks, and heavy duty trucks in the automotive aftermarket.

Dorman Products Inc. is based out of Colmar, PA and has some 1,785 employees. Its CEO is Mathias J. Barton.

For a complete fundamental analysis analysis of Dorman Products Inc., check out’s Stock Valuation Analysis report for DORM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…